Chemistry:Ethyltestosterone
 | |
| Clinical data | |
|---|---|
| Other names | 17α-Ethyltestosterone; 17α-Ethylandrost-4-en-17β-ol-3-one; 17α-Pregn-4-en-17-ol-3-one |
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C21H32O2 |
| Molar mass | 316.485 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Ethyltestosterone, or 17α-ethyltestosterone, also known as 17α-ethylandrost-4-en-17β-ol-3-one or 17α-pregn-4-en-17-ol-3-one, is a synthetic, orally active anabolic–androgenic steroid (AAS) of the 17α-alkylated group related to methyltestosterone which was never marketed.[1][2] Like methyltestosterone, ethyltestosterone is the parent compound of many AAS.[3] Derivatives of ethyltestosterone include norethandrolone (ethylnandrolone, ethylestrenolone), ethylestrenol (ethylnandrol), norboletone, ethyldienolone, tetrahydrogestrinone, bolenol (ethylnorandrostenol), and propetandrol.[3]
Ethyltestosterone is described as a very weak AAS[4][5] and is considerably weaker as an AAS than is methyltestosterone.[6] It is reported to have 1/10 of the anabolic potency and 1/20 of the androgenic potency of testosterone propionate in rodents.[7] Ethyltestosterone was also inactive in boys with dwarfism at 20 to 40 mg/day orally.[7] The low potency of ethyltestosterone is in notable contrast to norethandrolone (17α-ethyl-19-nortestosterone), the C19 nor analogue.[4] Analogues of ethyltestosterone with longer C17α chains such as propyltestosterone (topterone) have further reduced androgenic activity or even antiandrogenic activity.[2][8] In contrast to ethyltestosterone, its 19-demethyl variant, norethandrolone, is a potent AAS comparable in anabolic activity to testosterone propionate.[5]
See also
- List of androgens/anabolic steroids
References
- ↑ Dictionary of Steroids. CRC Press. 23 May 1991. pp. 423–. ISBN 978-0-412-27060-4. https://books.google.com/books?id=AI7EnUyeEtUC&pg=PA423.
- ↑ 2.0 2.1 "The myotrophic and androgenic effects of 17-ethyl-19-nortestosterone and related compounds". Endocrinology 58 (5): 567–572. May 1956. doi:10.1210/endo-58-5-567. PMID 13317831.
- ↑ 3.0 3.1 "A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids". Clinical Therapeutics 23 (9): 1355–1390. September 2001. doi:10.1016/s0149-2918(01)80114-4. PMID 11589254.
- ↑ 4.0 4.1 "Anabolic Steroids". Fortschritte der Arzneimittelforschung / Progress in Drug Research / Progrès des recherches pharmaceutiques. 2. Birkhäuser. 1960. 71–134. doi:10.1007/978-3-0348-7038-2_2. ISBN 978-3-0348-7040-5.
- ↑ 5.0 5.1 "17-Alkyl-19-nortestosterones". Journal of the American Chemical Society 79 (5): 1123–1127. 1957. doi:10.1021/ja01562a028. ISSN 0002-7863.
- ↑ Chemistry of vitamins and hormones. Andhra Univ.. 1952. https://books.google.com/books?id=woQZAAAAIAAJ.
- ↑ 7.0 7.1 "Structure-activity relationships of anabolic steroids: role of the 19-methyl group". The Journal of Clinical Endocrinology and Metabolism 19 (8): 921–935. August 1959. doi:10.1210/jcem-19-8-921. PMID 14442516.
- ↑ "Androgen receptor antagonists (antiandrogens): structure-activity relationships". Current Medicinal Chemistry 7 (2): 211–247. February 2000. doi:10.2174/0929867003375371. PMID 10637363.
 |  |
